Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase ActivityJack D. Scott, Michael W. Miller, Duane E. DeMong et al.|Journal of Medicinal Chemistry|2017Cited by 147
Seismic isolation enhancements for initial and advanced LIGOR. Abbott, D. C. Coyne, E. J. Daw et al.|Classical and Quantum Gravity|2004Cited by 68
Quiet Hydraulic Actuators for LIGOC. Hardham, M. E. Zucker, B. Abbott et al.|IFAC Proceedings Volumes|2006Cited by 8